Buspar and Breast cancer - a phase IV clinical study of FDA data

Summary:

Breast cancer is found among people who take Buspar, especially for people who are female, 50-59 old.

The phase IV clinical study analyzes which people take Buspar and have Breast cancer. It is created by eHealthMe based on reports of 16,539 people who have side effects when taking Buspar from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

16,539 people reported to have side effects when taking Buspar.
Among them, 42 people (0.25%) have Breast cancer.

What is Buspar?

Buspar has active ingredients of buspirone hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 19,125 Buspar users for its effectiveness, alternative drugs and more.

What is Breast cancer?

Breast cancer is found to be associated with 2,287 drugs and 1,568 conditions by eHealthMe.

Number of Buspar and Breast cancer reports submitted per year:

Gender of people who have Breast cancer when taking Buspar *:

female: 97.56 %
male: 2.44 %

Age of people who have Breast cancer when taking Buspar *:

Common drugs people take besides Buspar *:

Common side effects people have besides Breast cancer *:

Osteopenia (a condition where bone mineral density is lower than normal): 20 people, 47.62%
Breast Pain: 19 people, 45.24%
Fall: 16 people, 38.10%
High Blood Pressure: 15 people, 35.71%
Fatigue (feeling of tiredness): 13 people, 30.95%
Muscle Spasms (muscle contraction): 13 people, 30.95%
Hot Flush (sudden feelings of heat): 13 people, 30.95%
Breathing Difficulty: 12 people, 28.57%
Pain: 12 people, 28.57%
Joint Pain: 12 people, 28.57%

Common conditions people have *:

Menopause (end of monthly cycles in women): 19 people, 45.24%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 16.67%
Sleep Disorder: 6 people, 14.29%
Pain: 4 people, 9.52%
High Blood Pressure: 4 people, 9.52%
Metastases To Bone (cancer spreads to bone): 4 people, 9.52%
Fatigue (feeling of tiredness): 3 people, 7.14%
Insomnia (sleeplessness): 3 people, 7.14%
Bladder Disorder: 3 people, 7.14%
Infection: 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Buspar and have Breast cancer?

Check whether Breast cancer is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Breast cancer and when was it recovered:

Breast cancer in Buspar

Expand to all the drugs that have ingredients of buspirone hydrochloride:

Breast cancer and drugs with ingredients of buspirone hydrochloride (85 reports)

Alternative drugs to, pros and cons of Buspar:

Buspar (19,125 reports)

Common Buspar side effects:

Stress and anxiety: 1,605 reports
Fatigue (feeling of tiredness): 1,244 reports
Depression: 1,199 reports
Drug ineffective: 1,196 reports
Headache (pain in head): 1,147 reports
Pain: 1,084 reports
Insomnia (sleeplessness): 982 reports

Browse all side effects of Buspar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Breast cancer treatments and more:

Breast cancer (239,493 reports)

COVID vaccines that are related to Breast cancer:

Common drugs associated with Breast cancer:

Zantac: 31,011 reports
Ranitidine: 25,585 reports
Premarin: 16,321 reports
Prempro: 14,715 reports
Provera: 13,179 reports
Ranitidine hydrochloride: 9,833 reports
Medroxyprogesterone acetate: 2,765 reports
Cycrin: 2,674 reports
Methotrexate: 2,641 reports
Enbrel: 2,572 reports

All the drugs that are associated with Breast cancer:

Breast cancer (2,287 drugs)

Common conditions associated with Breast cancer:

Indigestion: 31,587 reports
Gastroesophageal reflux disease: 21,862 reports
Hormone replacement therapy: 10,641 reports
Multiple sclerosis: 4,855 reports
Rheumatoid arthritis: 4,688 reports
Gastric ulcer: 4,174 reports
High blood pressure: 2,148 reports

All the conditions that are associated with Breast cancer:

Breast cancer (1,568 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on buspirone hydrochloride (the active ingredients of Buspar) and Buspar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.